MedPath

A clinical trial to study the comparison of hydrophilic intraocular lens and silicone lens in children undergoing cataract surgery

Conditions
Pediatric cataract
Registration Number
CTRI/2010/091/000195
Lead Sponsor
Dr Jagat Ram
Brief Summary

This prospective clinical study was conducted among children (age 1month to 8 years) with congenital/developmental cataract in a tertiary care centre. The children were randomly divided into two groups. All participants underwent phacoaspiration, primary posterior capsulotomy and anterior vitrectomy. Group A (n=21) was implanted with acrylic hydrophobic, AcrySof SA60AT® intra ocular lens (IOL), where as Group B (n=20) was implanted with silicone, Tecnis Z9000® IOL. The children were evaluated for anterior chamber reaction, IOL position, posterior capsular opacification (PCO), intraocular pressure (IOP), best corrected visual acuity (BCVA), corneal status and refractive errors.Postoperatively, two eyes in each group had significant anterior chamber reaction with fibrin membrane formation. Cornea was clear in both groups. IOLs were in the capsular bag in all but one eye in both groups. Seven eyes in the acrylic group and six eyes in the silicone group achieved visual acuity of 20/40 or better. None of the eye had glaucoma. Best corrected visual acuity (BCVA) at one year was similar in both groups. In the acrylic hydrophobic group, 14 eyes needed hypermetropic correction and 7 eyes were myopic where as in the silicone group 10 eyes had myopia and 10 eyes had hypermetropia at 1 year postoperatively. Posterior capsule opacification at one year postoperative was more common in eyes implanted with acrylic hydrophobic IOL (5 eyes) than in silicone IOL (2 eyes).

Detailed Description

Not available

Recruitment & Eligibility

Sex
Not specified
Target Recruitment
41
Inclusion Criteria
  • (a) Children, aged one month to eight years, with visually significant congenital or developmental cataract.
  • (b) Partial or dense, visually significant cataract, involving 3 mm or more of the central visual axis.
Exclusion Criteria
  • (a) Presence of an associated ocular disease such as microphthalmia, microcornea, glaucoma, uveitis, complicated cataract, posterior lenticonus, coloboma, subluxated lens, retinal lesions like retinal detachment, retinal holes etc.
  • (b) Suspected pre existing posterior capsular defects like traumatic cataract (c) Systemic diseases (d) Children in whom the axial length of the eye < 17mm.

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visual axis opacification (VAO), PCO, membranectomy rates for significant VAOone year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PGIMER

🇮🇳

Chandigarh, CHANDIGARH, India

PGIMER
🇮🇳Chandigarh, CHANDIGARH, India
Dr Jagat ram
Principal investigator
01722756111
drjagatram@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.